Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.Considering these trends, value investing is clearly one of the most preferred ways to find strong stocks in any type of market. Value investors rely on traditional forms of analysis on key valuation metrics to find stocks that they believe are unde ...

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors use tried-and-true metrics and fundamental a ...

Shares of Madrigal Pharmaceuticals (MDGL) lost 9.7% on Tuesday as the investors were not impressed by its preliminary fourth-quarter and full-year 2024 results. The company’s top line comprises only its product revenues. Madrigal’s commercial portfolio has one marketed drug, Rezdiffra (resmetirom), a once-daily, oral and liver-directed THR-β agonist.Rezdiffra gained the FDA’s accelerated approval in March 2024 for adult patients with nonalcoholic steatohepatitis (NASH). Subsequently, the drug became the fir ...

Planet Labs PBC (PL) shares have been on a remarkable run with an impressive return of 80.5% over the past year. Over the same time frame, Planet Labs has comfortably outperformed the broader Zacks Computer and Technology sector and the Zacks  Internet – Software industry’s return of 29.2% and 31.4%, respectively. The stock has also outperformed its industry peers, including Compass (COMP) and HashiCorp (HCP) . Shares of COMP and HCP have gained 73.3% and 58.3%, respectively, over the past year.The outstand ...

Community Trust Bancorp (CTBI) came out with quarterly earnings of $1.25 per share, beating the Zacks Consensus Estimate of $1.20 per share. This compares to earnings of $1.04 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 4.17%. A quarter ago, it was expected that this bank holding company for Community Trust Bank would post earnings of $1.15 per share when it actually produced earnings of $1.23, delivering a surprise of 6. ...

The Zacks Style Scores is a unique set of guidelines that rates stocks based on three popular investing types, and were developed as complementary indicators for the Zacks Rank. This combination helps investors choose securities with the highest chances of beating the market over the next 30 days. Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of the Zacks Ran ...

United Airlines (UAL) is set to release its fourth-quarter 2024 results on Jan. 21, after market close.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.The Zacks Consensus Estimate for fourth-quarter 2024 earnings has been revised 1.7% upward in the past 60 days and is pegged at $3.01 per share. Additionally, the consensus mark implies a 50.5% uptick from the year-ago actual. The Zacks Consensus Estimate for fourth-quarter 2024 revenues is pegged at $14.4 billion, indicating a 5.6% u ...

IDEXX’s (IDXX) business continues to be dampened by currency impacts and uncertain macroeconomic conditions. The stock carries a Zacks Rank #4 (Sell) currently.Concerning Factors for IDXXIn recent times, U.S. clinical visit growth levels have been constrained by persistent staffing challenges at veterinary clinics and the cumulative impacts of broader macroeconomic challenges on consumers. Meanwhile, challenges in the Asia-Pacific, including the impacts of reduced swine testing in China and lower health scr ...

Kymera Therapeutics, Inc. (KYMR) shares rallied 7.8% in the last trading session to close at $40.12. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 13.6% loss over the past four weeks.Shares gained as investors were impressed by the pipeline updates provided by the company at the J.P. Morgan Annual Healthcare Conference. Kymera has a sound cash position and ended 2024 with an estimated cash of $850 million, ...

公司分析 - Equinor (EQNR) 是一家全球领先的综合能源公司，业务遍布30个国家，Zacks评级为1（强力买入），过去60天内当前年度盈利的Zacks共识预期增长了1.8% [1] - Equinor的市盈率（P/E）为7.63，低于行业的9.00，价值评分为A [2] - GIII Apparel Group (GIII) 是一家设计、制造和分销服装及配饰的公司，拥有授权品牌、自有品牌和私人标签品牌，Zacks评级为1，过去60天内当前年度盈利的Zacks共识预期增长了3.7% [2] - GIII Apparel Group的市盈率（P/E）为7.34，远低于行业的20.60，价值评分为B [3] - First Horizon (FHN) 是一家多元化的金融服务公司，提供区域银行、抵押贷款、产权保险、专业商业贷款、商业租赁和设备融资、经纪、财富管理和资本市场服务，Zacks评级为1，过去60天内当前年度盈利的Zacks共识预期增长了0.7% [4] - First Horizon的市盈率（P/E）为13.17，低于行业的17.10，价值评分为B [5] 行业对比 - Equinor的市盈率显著低于行业平均水平，显示出较高的价值吸引力 [2] - GIII Apparel Group的市盈率远低于行业平均水平，表明其估值相对较低 [3] - First Horizon的市盈率也低于行业平均水平，显示出一定的价值优势 [5]